Becton Dickinson & Co (BDX): Today's Featured Health Services Winner - TheStreet

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

Becton Dickinson



) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.9%. By the end of trading, Becton Dickinson rose $1.66 (1.7%) to $97.69 on heavy volume. Throughout the day, 1,647,635 shares of Becton Dickinson exchanged hands as compared to its average daily volume of 1,000,500 shares. The stock ranged in a price between $94.25-$97.76 after having opened the day at $94.85 as compared to the previous trading day's close of $96.03. Other companies within the Health Services industry that increased today were:

Vanguard Health Systems



), up 67.3%,

USMD Holdings



), up 17.9%,




), up 9.1% and

Thermogenesis Corporation



), up 6.3%.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. Becton Dickinson has a market cap of $18.7 billion and is part of the health care sector. The company has a P/E ratio of 17.2, below the S&P 500 P/E ratio of 17.7. Shares are up 22.8% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate Becton Dickinson a buy, 5 analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates

Becton Dickinson

as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front,

Pingtan Marine Enterprise



), down 64.2%,

Vision-Sciences Inc (DE



), down 10.6%,




), down 9.0% and

BG Medicine



), down 8.1% , were all laggards within the health services industry with




) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR



) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care




3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.